Skip to main content
Premium Trial:

Request an Annual Quote

Celera Net Loss Narrows, Q1 Revenues Down

NEW YORK, Oct. 22 (GenomeWeb News) - Celera Genomics this morning reported a net loss of $16.3 million for its first fiscal quarter ending Sept. 30, compared to a net loss of $19.6 million for the same period last year.


The Rockville, Md.-based company had revenues of $17.3 million for the quarter, compared to $23.5 million for the year-ago quarter. Of this revenue, online information business revenue decreased to $15.3 million for the first quarter, compared to $20.6 million in the same period last year.


The company had R&D expenses of $21.8 million, compared to $32.5 million for the fourth quarter of 2002.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.